Effects of RM-493 on Energy Expenditure in Obese Individuals

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
ObesityMorbid Obesity
Interventions
DRUG

Placebo

Sterile solution (vehicle) for subcutaneous infusion

DRUG

RM-493

Sterile solution (2mg/ml) for subcutaneous infusion

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Rhythm Pharmaceuticals, Inc.

INDUSTRY

NCT01867437 - Effects of RM-493 on Energy Expenditure in Obese Individuals | Biotech Hunter | Biotech Hunter